Jasper Therapeutics Inc
NASDAQ:JSPR

Watchlist Manager
Jasper Therapeutics Inc Logo
Jasper Therapeutics Inc
NASDAQ:JSPR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 52m USD

Intrinsic Value

The intrinsic value of one JSPR stock under the Base Case scenario is 2.56 USD. Compared to the current market price of 1.86 USD, Jasper Therapeutics Inc is Undervalued by 27%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JSPR Intrinsic Value
2.56 USD
Undervaluation 27%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Jasper Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about JSPR?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is JSPR valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Jasper Therapeutics Inc.

Explain Valuation
Compare JSPR to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about JSPR?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jasper Therapeutics Inc

Current Assets 54.6m
Cash & Short-Term Investments 50.9m
Other Current Assets 3.7m
Non-Current Assets 2.9m
PP&E 2.3m
Other Non-Current Assets 567k
Current Liabilities 21m
Accounts Payable 9.2m
Accrued Liabilities 11.8m
Other Current Liabilities 63k
Non-Current Liabilities 24.9m
Other Non-Current Liabilities 24.9m
Efficiency

Free Cash Flow Analysis
Jasper Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jasper Therapeutics Inc

Revenue
0 USD
Operating Expenses
-93.3m USD
Operating Income
-93.3m USD
Other Expenses
2.3m USD
Net Income
-91m USD
Fundamental Scores

JSPR Profitability Score
Profitability Due Diligence

Jasper Therapeutics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Jasper Therapeutics Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

JSPR Solvency Score
Solvency Due Diligence

Jasper Therapeutics Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
51/100
Solvency
Score

Jasper Therapeutics Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JSPR Price Targets Summary
Jasper Therapeutics Inc

There are no price targets for JSPR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Jasper Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for JSPR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

JSPR Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one JSPR stock?

The intrinsic value of one JSPR stock under the Base Case scenario is 2.56 USD.

Is JSPR stock undervalued or overvalued?

Compared to the current market price of 1.86 USD, Jasper Therapeutics Inc is Undervalued by 27%.

Back to Top